;PMID: 10402253
;source_file_1214.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..33] = [t:0..33]
;1)sentence:[e:38..159] = [t:38..159]
;2)section:[e:163..211] = [t:163..211]
;3)section:[e:215..310] = [t:215..310]
;4)sentence:[e:314..485] = [t:314..485]
;5)sentence:[e:486..631] = [t:486..631]
;6)sentence:[e:633..879] = [t:633..879]
;7)sentence:[e:880..1095] = [t:880..1095]
;8)section:[e:1099..1144] = [t:1099..1144]

;section 0 Span:0..33
;Int J Oncol  1999 Aug;15(2):391-8
(SEC
  (FRAG (NNP:[0..3] Int) (NNP:[4..5] J) (NNP:[6..11] Oncol) (CD:[13..17] 1999)
        (.:[18..25] Aug;15-LRB-) (CD:[25..26] 2) (-RRB-:[26..27] -RRB-)
        (CD:[27..31] :391) (::[31..32] -) (CD:[32..33] 8)))

;sentence 1 Span:38..159
;Sampling technique influences the detection of K-ras mutations in normal 
;appearing mucosa of colorectal cancer patients.
;[85..90]:gene-rna:"K-ras"
;[132..149]:malignancy:"colorectal cancer"
(SENT
  (S
    (S-NOM-SBJ
      (NP-SBJ (-NONE-:[38..38] *))
      (VP (VBG:[38..46] Sampling)
        (NP (NN:[47..56] technique))))
    (VP (VBZ:[57..67] influences)
      (NP
        (NP (DT:[68..71] the) (NN:[72..81] detection))
        (PP (IN:[82..84] of)
          (NP (NN:[85..90] K-ras) (NNS:[91..100] mutations)))
        (PP-LOC (IN:[101..103] in)
          (NP
            (NP
              (ADJP (JJ:[104..110] normal) (VBG:[112..121] appearing))
              (NN:[122..128] mucosa))
            (PP (IN:[129..131] of)
              (NP
                (NML (JJ:[132..142] colorectal) (NN:[143..149] cancer))
                (NNS:[150..158] patients)))))))
    (.:[158..159] .)))

;section 2 Span:163..211
;Schimanski CC, Sutter C, Linnemann U, Berger MR.
(SEC
  (FRAG (NNP:[163..173] Schimanski) (NNP:[174..176] CC) (,:[176..177] ,)
        (NNP:[178..184] Sutter) (NNP:[185..186] C) (,:[186..187] ,)
        (NNP:[188..197] Linnemann) (NNP:[198..199] U) (,:[199..200] ,)
        (NNP:[201..207] Berger) (NNP:[208..210] MR) (.:[210..211] .)))

;section 3 Span:215..310
;Unit of Toxicology and Chemotherapy, German Cancer Research Centre, 69120 
;Heidelberg, Germany.
(SEC
  (FRAG (NNP:[215..219] Unit) (IN:[220..222] of) (NNP:[223..233] Toxicology)
        (CC:[234..237] and) (NNP:[238..250] Chemotherapy) (,:[250..251] ,)
        (NNP:[252..258] German) (NNP:[259..265] Cancer)
        (NNP:[266..274] Research) (NNP:[275..281] Centre) (,:[281..282] ,)
        (CD:[283..288] 69120) (NNP:[290..300] Heidelberg) (,:[300..301] ,)
        (NNP:[302..309] Germany) (.:[309..310] .)))

;sentence 4 Span:314..485
;Based on three colorectal cancer cell lines with specified K-ras status, a 
;sensitive PCR-RFLP assay was established detecting one K-ras mutant among 106
; wild-type cells.
;[329..357]:malignancy:"colorectal cancer cell lines"
;[373..378]:gene-rna:"K-ras"
;[445..450]:gene-rna:"K-ras"
(SENT
  (S
    (PP (VBN:[314..319] Based)
      (PP (IN:[320..322] on)
        (NP
          (NP (CD:[323..328] three)
             (JJ:[329..339] colorectal) (NN:[340..346] cancer)
             (NN:[347..351] cell) (NN:[352..357] lines))
          (PP (IN:[358..362] with)
            (NP (VBN:[363..372] specified) (NN:[373..378] K-ras)
                (NN:[379..385] status))))))
    (,:[385..386] ,)
    (NP-SBJ-1 (DT:[387..388] a) (JJ:[390..399] sensitive)
      (NML (NN:[400..403] PCR) (HYPH:[403..404] -) (NN:[404..408] RFLP))
      (NN:[409..414] assay))
    (VP (VBD:[415..418] was)
      (VP (VBN:[419..430] established)
        (NP-1 (-NONE-:[430..430] *))
        (S-ADV
          (NP-SBJ (-NONE-:[430..430] *))
          (VP (VBG:[431..440] detecting)
            (NP
              (NP (CD:[441..444] one) (NN:[445..450] K-ras)
                  (NN:[451..457] mutant))
              (PP (IN:[458..463] among)
                (NP (CD:[464..467] 106)
                  (NML (JJ:[469..473] wild) (HYPH:[473..474] -)
                       (NN:[474..478] type))
                  (NNS:[479..484] cells))))))))
    (.:[484..485] .)))

;sentence 5 Span:486..631
;Using this assay for tissues of 124 colorectal cancer patients,  59 tumor
;(46%) and 11 mucosa samples (9%) were found to harbor a K-ras mutation.
;[522..539]:malignancy:"colorectal cancer"
;[554..559]:malignancy:"tumor"
;[616..621]:gene-rna:"K-ras"
(SENT
  (S
    (S-MNR
      (NP-SBJ (-NONE-:[486..486] *))
      (VP (VBG:[486..491] Using)
        (NP
          (NP (DT:[492..496] this) (NN:[497..502] assay))
          (PP (IN:[503..506] for)
            (NP
              (NP (NNS:[507..514] tissues))
              (PP (IN:[515..517] of)
                (NP (CD:[518..521] 124)
                  (NML (JJ:[522..532] colorectal) (NN:[533..539] cancer))
                  (NNS:[540..548] patients))))))))
    (,:[548..549] ,)
    (NP-SBJ-1
      (NP (CD:[551..553] 59) (NN:[554..559] tumor)
        (PRN (-LRB-:[560..561] -LRB-)
          (NP (CD:[561..563] 46) (NN:[563..564] %))
          (-RRB-:[564..565] -RRB-)))
      (CC:[566..569] and)
      (NP (CD:[570..572] 11) (NN:[573..579] mucosa) (NNS:[580..587] samples)
        (PRN (-LRB-:[588..589] -LRB-)
          (NP (CD:[589..590] 9) (NN:[590..591] %))
          (-RRB-:[591..592] -RRB-))))
    (VP (VBD:[593..597] were)
      (VP (VBN:[598..603] found)
        (S
          (NP-SBJ-1 (-NONE-:[603..603] *))
          (VP (TO:[604..606] to)
            (VP (VB:[607..613] harbor)
              (NP (DT:[614..615] a) (NN:[616..621] K-ras)
                  (NN:[622..630] mutation)))))))
    (.:[630..631] .)))

;sentence 6 Span:633..879
;When using the same scalpel for collecting tumor and mucosa tissues (group
;A),  18% of the patients had a matching K-ras mutation in both tissues, but
;this  coincidence was seen in 3% of patients only, when separate scalpels
;were used  (group B).
;[676..681]...[693..700]:malignancy:"tumor"..."tissues"
;[748..753]:gene-rna:"K-ras"
(SENT
  (S
    (S
      (SBAR
        (WHADVP-2 (WRB:[633..637] When))
        (S
          (NP-SBJ (-NONE-:[637..637] *))
          (VP (VBG:[638..643] using)
            (NP (DT:[644..647] the) (JJ:[648..652] same) (NN:[653..660] scalpel))
            (PP-PRP (IN:[661..664] for)
              (S-NOM
                (NP-SBJ (-NONE-:[664..664] *))
                (VP (VBG:[665..675] collecting)
                  (NP
                    (NP (NN:[676..681] tumor)
                      (NML-1 (-NONE-:[681..681] *P*)))
                    (CC:[682..685] and)
                    (NP (JJ:[686..692] mucosa)
                      (NML-1 (NNS:[693..700] tissues)))))))
            (PRN (-LRB-:[701..702] -LRB-)
              (NP (NN:[702..707] group) (NN:[708..709] A))
              (-RRB-:[709..710] -RRB-))
            (ADVP-TMP-2 (-NONE-:[710..710] *T*)))))
      (,:[710..711] ,)
      (NP-SBJ
        (NP (CD:[713..715] 18) (NN:[715..716] %))
        (PP (IN:[717..719] of)
          (NP (DT:[720..723] the) (NNS:[724..732] patients))))
      (VP (VBD:[733..736] had)
        (NP (DT:[737..738] a) (VBG:[739..747] matching) (NN:[748..753] K-ras)
            (NN:[754..762] mutation))
        (PP-LOC (IN:[763..765] in)
          (NP (DT:[766..770] both) (NNS:[771..778] tissues)))))
    (,:[778..779] ,) (CC:[780..783] but)
    (S
      (NP-SBJ-3 (DT:[784..788] this) (NN:[790..801] coincidence))
      (VP (VBD:[802..805] was)
        (VP (VBN:[806..810] seen)
          (NP-3 (-NONE-:[810..810] *))
          (PP (IN:[811..813] in)
            (NP
              (NP (CD:[814..815] 3) (NN:[815..816] %))
              (PP (IN:[817..819] of)
                (NP (NNS:[820..828] patients)))
              (ADVP (RB:[829..833] only))))
          (,:[833..834] ,)
          (SBAR-ADV
            (WHADVP-5 (WRB:[835..839] when))
            (S
              (NP-SBJ-4 (JJ:[840..848] separate) (NNS:[849..857] scalpels))
              (VP (VBD:[858..862] were)
                (VP (VBN:[863..867] used)
                  (NP-4 (-NONE-:[867..867] *))
                  (PRN (-LRB-:[869..870] -LRB-)
                    (NP (NN:[870..875] group) (NN:[876..877] B))
                    (-RRB-:[877..878] -RRB-))
                  (ADVP-TMP-5 (-NONE-:[878..878] *T*)))))))))
    (.:[878..879] .)))

;sentence 7 Span:880..1095
;Thus we conclude that the sampling technique used for collecting  specimens
;is a major contributor to the detection of K-ras mutations in normal 
;appearing mucosa when a highly sensitive detection technique is used.
;[999..1004]:gene-rna:"K-ras"
(SENT
  (S
    (ADVP (RB:[880..884] Thus))
    (NP-SBJ (PRP:[885..887] we))
    (VP (VBP:[888..896] conclude)
      (SBAR (IN:[897..901] that)
        (S
          (NP-SBJ
            (NP (DT:[902..905] the) (VBG:[906..914] sampling)
                (NN:[915..924] technique))
            (VP (VBN:[925..929] used)
              (NP (-NONE-:[929..929] *))
              (PP (IN:[930..933] for)
                (S-NOM
                  (NP-SBJ (-NONE-:[933..933] *))
                  (VP (VBG:[934..944] collecting)
                    (NP (NNS:[946..955] specimens)))))))
          (VP (VBZ:[956..958] is)
            (NP-PRD
              (NP (DT:[959..960] a) (JJ:[961..966] major)
                  (NN:[967..978] contributor))
              (PP (TO:[979..981] to)
                (NP
                  (NP (DT:[982..985] the) (NN:[986..995] detection))
                  (PP (IN:[996..998] of)
                    (NP (NN:[999..1004] K-ras) (NNS:[1005..1014] mutations)))
                  (PP (IN:[1015..1017] in)
                    (NP
                      (ADJP (JJ:[1018..1024] normal)
                            (VBG:[1026..1035] appearing))
                      (NN:[1036..1042] mucosa))))))
            (SBAR
              (WHADVP-2 (WRB:[1043..1047] when))
              (S
                (NP-SBJ-1 (DT:[1048..1049] a)
                  (ADJP (RB:[1050..1056] highly) (JJ:[1057..1066] sensitive))
                  (NN:[1067..1076] detection) (NN:[1077..1086] technique))
                (VP (VBZ:[1087..1089] is)
                  (VP (VBN:[1090..1094] used)
                    (NP-1 (-NONE-:[1094..1094] *))
                    (ADVP-TMP-2 (-NONE-:[1094..1094] *T*))))))))))
    (.:[1094..1095] .)))

;section 8 Span:1099..1144
;PMID: 10402253 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1099..1103] PMID) (::[1103..1104] :) (CD:[1105..1113] 10402253)
        (NN:[1114..1115] -LSB-) (NNP:[1115..1121] PubMed) (::[1122..1123] -)
        (NN:[1124..1131] indexed) (IN:[1132..1135] for)
        (NNP:[1136..1144] MEDLINE-RSB-)))
